LeadIQ logo
Learn more at LeadIQ.com

Insights

Rare Disease Therapies Agios Pharmaceuticals focuses on developing life-changing therapies for rare diseases, showcasing a commitment to addressing unmet medical needs in niche markets. This presents an opportunity for targeted sales strategies in specialized healthcare segments.

Strategic Partnerships Agios Pharmaceuticals has established strategic partnerships with companies like Alnylam, indicating a collaborative approach to innovation. Leveraging these partnerships, sales teams can explore cross-selling opportunities and expand market reach through combined product offerings.

Board of Directors Expansion Recent additions to Agios Pharmaceuticals' board of directors, such as Catherine Owen and Jeffrey Capello, bring diverse expertise to the company. Sales professionals can connect with these directors to gain insights, forge strategic alliances, and open doors to potential business opportunities.

Financial Stability With a revenue ranging between $50M - $100M and a funding of $256M, Agios Pharmaceuticals showcases financial stability. Utilizing this information, sales development representatives can capitalize on the company's robust financial position to negotiate favorable terms and secure long-term partnerships.

Market Expansion through Acquisition Agios Pharmaceuticals' asset sale to Cstonepharma and acquisition of rights from Alnylam highlight a strategic approach to market expansion. Sales teams can explore opportunities arising from such transactions, positioning themselves as valuable partners in the company's growth trajectory.

Similar companies to Agios Pharmaceuticals

Agios Pharmaceuticals Tech Stack

Agios Pharmaceuticals uses 8 technology products and services including Microsoft Word, Google Font API, Google Charts, and more. Explore Agios Pharmaceuticals's tech stack below.

  • Microsoft Word
    Editors
  • Google Font API
    Font Scripts
  • Google Charts
    Javascript Graphics
  • Exhibit
    Javascript Graphics
  • Open Graph
    Miscellaneous
  • Java
    Programming Languages
  • ARGUS
    Real Estate Marketing
  • CVS
    Source Code Management

Media & News

Agios Pharmaceuticals's Email Address Formats

Agios Pharmaceuticals uses at least 1 format(s):
Agios Pharmaceuticals Email FormatsExamplePercentage
First.Last@agios.comJohn.Doe@agios.com
94%
F.Last@agios.comJ.Doe@agios.com
3%
LastF@agios.comDoeJ@agios.com
2%
Last@agios.comDoe@agios.com
1%

Frequently Asked Questions

Where is Agios Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Agios Pharmaceuticals's main headquarters is located at 88 Sidney Street Cambridge, MA 02139 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Agios Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Agios Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Agios Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Agios Pharmaceuticals is a publicly traded company; the company's stock symbol is AGIO.

What is Agios Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Agios Pharmaceuticals's official website is agios.com and has social profiles on LinkedIn.

How much revenue does Agios Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of September 2024, Agios Pharmaceuticals's annual revenue reached $75M.

What is Agios Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Agios Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Agios Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of September 2024, Agios Pharmaceuticals has approximately 585 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: C. J.Chief Technical Operations Officer: C. P.Chief Legal Officer: J. B.. Explore Agios Pharmaceuticals's employee directory with LeadIQ.

What industry does Agios Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Agios Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Agios Pharmaceuticals use?

Minus sign iconPlus sign icon
Agios Pharmaceuticals's tech stack includes Microsoft WordGoogle Font APIGoogle ChartsExhibitOpen GraphJavaARGUSCVS.

What is Agios Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Agios Pharmaceuticals's email format typically follows the pattern of . Find more Agios Pharmaceuticals email formats with LeadIQ.

How much funding has Agios Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of September 2024, Agios Pharmaceuticals has raised $256M in funding. The last funding round occurred on Nov 07, 2019 for $256M.

When was Agios Pharmaceuticals founded?

Minus sign iconPlus sign icon
Agios Pharmaceuticals was founded in 2008.
Agios Pharmaceuticals

Agios Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States501-1000 Employees

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. 

We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results.

Section iconCompany Overview

Headquarters
88 Sidney Street Cambridge, MA 02139 US
Phone number
Website
agios.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
AGIO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2008
Employees
501-1000

Section iconFunding & Financials

  • $256M

    Agios Pharmaceuticals has raised a total of $256M of funding over 7 rounds. Their latest funding round was raised on Nov 07, 2019 in the amount of $256M.

  • $50M$100M

    Agios Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $256M

    Agios Pharmaceuticals has raised a total of $256M of funding over 7 rounds. Their latest funding round was raised on Nov 07, 2019 in the amount of $256M.

  • $50M$100M

    Agios Pharmaceuticals's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.